VELETRI for Portopulmonary hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where VELETRI was used for Portopulmonary hypertension.
Most Reported Side Effects for VELETRI
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 59 | 17.7% | 25 | 52 |
| Death | 48 | 14.4% | 48 | 24 |
| Nausea | 36 | 10.8% | 12 | 26 |
| Pulmonary arterial hypertension | 34 | 10.2% | 17 | 30 |
| Pneumonia | 33 | 9.9% | 7 | 33 |
| Headache | 30 | 9.0% | 8 | 20 |
| Vomiting | 27 | 8.1% | 9 | 21 |
| Diarrhoea | 26 | 7.8% | 10 | 22 |
| Pain in jaw | 23 | 6.9% | 6 | 15 |
| Right ventricular failure | 23 | 6.9% | 20 | 18 |
| Fluid retention | 21 | 6.3% | 12 | 19 |
| Condition aggravated | 18 | 5.4% | 8 | 14 |
| Dizziness | 18 | 5.4% | 7 | 16 |
| Flushing | 18 | 5.4% | 4 | 12 |
| Malaise | 17 | 5.1% | 9 | 13 |
Other Indications for VELETRI
Pulmonary arterial hypertension (235)
Cor pulmonale chronic (43)
Product used for unknown indication (17)
Pulmonary hypertension (14)
Other Drugs Used for Portopulmonary hypertension
AMBRISENTAN (428)
MACITENTAN (153)
EPOPROSTENOL (52)
TREPROSTINIL (46)
SELEXIPAG (35)
LETAIRIS (29)
SILDENAFIL (29)
BOSENTAN (26)
TADALAFIL (16)
BOSENTAN\BOSENTAN (10)